← Eichor
Study identifier: NCT06937918 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot Study

Condition: Critical Illness · Fluid Over-load · Dynamic Arterial Elastance  ·  Sponsor: Mahidol University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To investigate the benefit of using the AFM and Eadyn-guided fluid and vasopressor therapy in septic shock resuscitation for mechanically ventilated patients compared with the standard of care. The investigators hypothesize that using the AFM and Eadyn-guided fluid/vasopressor titration in septic shock patients who underwent mechanical ventilation might reduce the time to shock reversal.

This description comes directly from the study's public registry record.

Talk to the study team

Ranistha Ratanarat, MD  ·  +66 2419 7767  ·  ranittha@gmail.com

Nuwara Pornawalai, MD  ·  +66 2419 7767  ·  nuwara.por@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Faculty of Medicine Siriraj HospitalBangkok Noi, Bangkok, ThailandNot Yet Recruiting
Siriraj Hospital, Mahidol UniversityBangkok, ThailandRecruiting
Siriraj Hospital, Mahidol UniversityBangkok, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06937918